Nolpaza (Pantoprazole)

Pantoprazole is a proton pump inhibitor used to manage acid‑related gastrointestinal conditions.

• Gastro‑oesophageal reflux disease (GERD): reduces gastric acid exposure, relieving heartburn and esophageal irritation.
• Erosive esophagitis: promotes healing of inflamed esophageal mucosa by suppressing acid secretion.
• Peptic ulcer disease: facilitates ulcer healing and reduces risk of recurrence through sustained acid suppression.
• Prevention of stress ulcers in critically ill patients: provides prophylactic acid control to lower the incidence of stress‑related gastric lesions.

• Pantoprazole irreversibly binds to the H+/K+ ATPase enzyme (gastric proton pump) located on the secretory surface of gastric parietal cells. By blocking this final step of acid production, it markedly reduces basal and stimulated gastric acid secretion, leading to an elevated gastric pH and allowing damaged mucosa to heal.

Pantoprazole may be associated with adverse reactions that vary in frequency and severity.

Common Side Effects

• Headache: mild to moderate pain often resolving without intervention.
• Diarrhea: loose stools that may be self‑limiting.
• Nausea: transient feeling of queasiness.
• Abdominal pain: discomfort in the upper abdomen.
• Constipation: reduced bowel movements.

Serious or Rare Side Effects

• Severe allergic reactions (anaphylaxis, angioedema): require immediate medical attention.
• Clostridioides difficile‑associated diarrhea: can be life‑threatening and needs prompt treatment.
• Electrolyte disturbances (hypomagnesemia, hypocalcemia): may cause muscle cramps or cardiac arrhythmias.
• Hepatic enzyme elevation: indicates possible liver injury.
• Stevens‑Johnson syndrome/toxic epidermal necrolysis: rare but serious skin reactions.

When using Nolpaza, consider the following precautions to ensure safe therapy.

• Renal impairment: monitor renal function and adjust therapy as needed.
• Hepatic impairment: use with caution; dose adjustment may be required.
• Elderly patients: observe for electrolyte imbalances and renal function changes.
• Concomitant antiplatelet therapy: increased risk of gastrointestinal bleeding; monitor closely.
• Known hypersensitivity to pantoprazole or other PPIs: contraindicated.
• Store at room temperature: keep in the original container, protect from light and moisture.

Pantoprazole can interact with several medicines; awareness of these interactions helps optimize patient outcomes.

Major Interactions (Avoid)

• Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk.
• Atazanavir: decreased absorption, leading to sub‑therapeutic antiviral levels.
• Methotrexate (high dose): increased serum concentrations, raising toxicity risk.

Moderate Interactions (Monitor Closely)

• Warfarin: possible increase in INR, requiring more frequent coagulation monitoring.
• Digoxin: may raise digoxin levels; monitor for signs of toxicity.
• HIV protease inhibitors (e.g., ritonavir): altered metabolism; adjust dosing as appropriate.